Alabama’s Republican Congressional delegation, including U.S. Reps. Gary Palmer, Robert Aderholt, Mike Rogers, Dale Strong, Barry Moore, and Jerry Carl, criticized the National Institute of Health (NIH) for lack of transparency regarding a study on the effects of puberty blockers for minors. The study, funded by NIH, reportedly showed that puberty blockers did not improve mental health in young people. The members of Congress sent a letter to NIH Director Monica M. Bertagnolli, M.D., requesting the release of all study details and expressing concern that the organization may be hindering child protection.
Palmer emphasized that taxpayers should not fund studies only to be denied access to results due to political agendas. He argued that the NIH should not cover up critical research on children’s health and safety. The delegation’s criticism comes amid a case before the U.S. Supreme Court involving Tennessee’s ban on certain health care treatments for transgender youths, which could have implications for Alabama’s similar law.
The issue raises questions about government-funded research and the transparency of its results, particularly when they involve children’s well-being. As the debate over puberty blockers and transgender health care continues, the need for accountability and openness in research becomes increasingly important. The delegation’s concerns highlight the broader societal discussion surrounding children’s health care and government-funded studies.
Source
Photo credit yellowhammernews.com